210 related articles for article (PubMed ID: 33158254)
1. (5-Hydroxy-4-oxo-2-styryl-4
Chen H; Zhang X; Zhang X; Liu W; Lei Y; Zhu C; Ma B
Molecules; 2020 Nov; 25(21):. PubMed ID: 33158254
[TBL] [Abstract][Full Text] [Related]
2. Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity.
Chen H; Zhang X; Zhang X; Fan Z; Liu W; Lei Y; Zhu C; Ma B
Bioorg Med Chem; 2020 Oct; 28(20):115699. PubMed ID: 33069078
[TBL] [Abstract][Full Text] [Related]
3. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of potent and multifunctional aldose reductase inhibitors based on quinoxalinones.
Qin X; Hao X; Han H; Zhu S; Yang Y; Wu B; Hussain S; Parveen S; Jing C; Ma B; Zhu C
J Med Chem; 2015 Feb; 58(3):1254-67. PubMed ID: 25602762
[TBL] [Abstract][Full Text] [Related]
5. A series of pyrido[2,3-b]pyrazin-3(4H)-one derivatives as aldose reductase inhibitors with antioxidant activity.
Han Z; Hao X; Ma B; Zhu C
Eur J Med Chem; 2016 Oct; 121():308-317. PubMed ID: 27267001
[TBL] [Abstract][Full Text] [Related]
6. Designing of acyl sulphonamide based quinoxalinones as multifunctional aldose reductase inhibitors.
Ji Y; Chen X; Chen H; Zhang X; Fan Z; Xie L; Ma B; Zhu C
Bioorg Med Chem; 2019 Apr; 27(8):1658-1669. PubMed ID: 30858026
[TBL] [Abstract][Full Text] [Related]
7. Phenolic 4-hydroxy and 3,5-dihydroxy derivatives of 3-phenoxyquinoxalin-2(1H)-one as potent aldose reductase inhibitors with antioxidant activity.
Zou Y; Qin X; Hao X; Zhang W; Yang S; Yang Y; Han Z; Ma B; Zhu C
Bioorg Med Chem Lett; 2015 Sep; 25(18):3924-7. PubMed ID: 26227780
[TBL] [Abstract][Full Text] [Related]
8. Pyridothiadiazine derivatives as aldose reductase inhibitors having antioxidant activity.
Zhu S; Zhang S; Hao X; Qin X; Parveen S; Yang S; Ma B; Zhu C
J Enzyme Inhib Med Chem; 2016; 31(sup1):126-130. PubMed ID: 27153454
[TBL] [Abstract][Full Text] [Related]
9. Identification of quinoxalin-2(1
Hao X; Qin X; Zhang X; Ma B; Qi G; Yu T; Han Z; Zhu C
Future Med Chem; 2019 Dec; 11(23):2989-3004. PubMed ID: 31659919
[No Abstract] [Full Text] [Related]
10. Synthesis and structure-activity relationship studies of phenolic hydroxyl derivatives based on quinoxalinone as aldose reductase inhibitors with antioxidant activity.
Hao X; Han Z; Li Y; Li C; Wang X; Zhang X; Yang Q; Ma B; Zhu C
Bioorg Med Chem Lett; 2017 Feb; 27(4):887-892. PubMed ID: 28109789
[TBL] [Abstract][Full Text] [Related]
11. (4-Oxo-2-thioxothiazolidin-3-yl)acetic acids as potent and selective aldose reductase inhibitors.
Kucerova-Chlupacova M; Halakova D; Majekova M; Treml J; Stefek M; Soltesova Prnova M
Chem Biol Interact; 2020 Dec; 332():109286. PubMed ID: 33038328
[TBL] [Abstract][Full Text] [Related]
12. Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
Mohd Siddique MU; Thakur A; Shilkar D; Yasmin S; Halakova D; Kovacikova L; Prnova MS; Stefek M; Acevedo O; Dasararaju G; Devadasan V; Mondal SK; Jayaprakash V
Eur J Med Chem; 2021 Nov; 223():113630. PubMed ID: 34175538
[TBL] [Abstract][Full Text] [Related]
13. Rhodanine-3-acetamide derivatives as aldose and aldehyde reductase inhibitors to treat diabetic complications: synthesis, biological evaluation, molecular docking and simulation studies.
Bacha MM; Nadeem H; Zaib S; Sarwar S; Imran A; Rahman SU; Ali HS; Arif M; Iqbal J
BMC Chem; 2021 Apr; 15(1):28. PubMed ID: 33906691
[TBL] [Abstract][Full Text] [Related]
14. Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase.
Carbone V; Zhao HT; Chung R; Endo S; Hara A; El-Kabbani O
Bioorg Med Chem; 2009 Feb; 17(3):1244-50. PubMed ID: 19121944
[TBL] [Abstract][Full Text] [Related]
15. Discovery of new inhibitors of aldose reductase from molecular docking and database screening.
Rastelli G; Ferrari AM; Costantino L; Gamberini MC
Bioorg Med Chem; 2002 May; 10(5):1437-50. PubMed ID: 11886806
[TBL] [Abstract][Full Text] [Related]
16. In vitro studies of potent aldose reductase inhibitors: Synthesis, characterization, biological evaluation and docking analysis of rhodanine-3-hippuric acid derivatives.
Celestina SK; Sundaram K; Ravi S
Bioorg Chem; 2020 Apr; 97():103640. PubMed ID: 32086051
[TBL] [Abstract][Full Text] [Related]
17. Novel 2-phenoxypyrido[3,2-
Hao X; Qi G; Ma H; Zhu C; Han Z
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1368-1372. PubMed ID: 31347930
[TBL] [Abstract][Full Text] [Related]
18. Effect of C7 modifications on benzothiadiazine-1,1-dioxide derivatives on their inhibitory activity and selectivity toward aldose reductase.
Zhang S; Chen X; Parveen S; Hussain S; Yang Y; Jing C; Zhu C
ChemMedChem; 2013 Apr; 8(4):603-13. PubMed ID: 23136050
[TBL] [Abstract][Full Text] [Related]
19. Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study.
Shehzad MT; Imran A; Njateng GSS; Hameed A; Islam M; Al-Rashida M; Uroos M; Asari A; Shafiq Z; Iqbal J
Bioorg Chem; 2019 Jun; 87():857-866. PubMed ID: 30551808
[TBL] [Abstract][Full Text] [Related]
20. Novel substituted N-benzyl(oxotriazinoindole) inhibitors of aldose reductase exploiting ALR2 unoccupied interactive pocket.
Hlaváč M; Kováčiková L; Šoltésová Prnová M; Addová G; Hanquet G; Štefek M; Boháč A
Bioorg Med Chem; 2021 Jan; 29():115885. PubMed ID: 33271452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
